Probing both tumor lysates and tissue sections with antibodies to regulators and targets of the Sororin/ERK feedback loop, confirmed that its activity was reduced in tumors derived from shIWS1 cells (Fig. 7c, Supplementary Fig. 11b). The gene discussed is CDCA5; the disease is neoplasm.